Fig. 11From: Effects of sodium‐glucose cotransporter type 2 inhibitors on cardiovascular, renal, and safety outcomes in patients with cardiovascular disease: a meta‐analysis of randomized controlled trialsNetwork meta-analysis for all outcomes of each drug compared with placebo. a All-cause mortality, b cardiovascular mortality, c HHF, d acute renal injury, e diabetic ketoacidosis adverse outcomesBack to article page